MedTrace Logo

The Effect of Orexin on Delayed Emergence of General Anesthesia in Dexmedetomidine

NCT03025295 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2021-06-23

No results posted yet for this study

Summary

The current study is designed to investigate the difference of plasma orexin A levels between Dexmedetomidine group and controlled group at emergence time from total intravenous anesthesia who will undergo elective lumbar surgery.

Conditions

  • Anesthesia

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine is common used to improve the prognosis and life quality of patients.

DRUG

Saline

It is safe Placebo.

Sponsors & Collaborators

  • General Hospital of Ningxia Medical University

    lead OTHER

Principal Investigators

  • Zhihua Wang, M.D. · General Hospital of Ningxia Medical University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025295 on ClinicalTrials.gov